tiprankstipranks
Biotest AG (GB:0N6Z)
LSE:0N6Z
UK Market

Biotest (0N6Z) Technical Analysis

Compare
0 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
0Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
0Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Biotest AG’s (0N6Z) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Biotest AG is a Buy.
Biotest AG’s (0N6Z) 20-Day exponential moving average is 41.64, while Biotest AG’s (0N6Z) share price is €41.2, making it a Sell.
Biotest AG’s (0N6Z) 50-Day exponential moving average is 41.63, while Biotest AG’s (0N6Z) share price is €41.2, making it a Sell.

Biotest (0N6Z) Pivot Points

Feb 23, 2025, 12:05 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
41.20
41.20
41.20
41.20
41.20
41.20
41.20
Fibonacci
41.20
41.20
41.20
41.20
41.20
41.20
41.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biotest (0N6Z) Moving Averages

Feb 23, 2025, 12:05 AM
Period
Simple
Exponential
MA5
41.20Sell
41.31Sell
MA10
41.60Sell
41.49Sell
MA20
41.80Sell
41.64Sell
MA50
41.52Sell
41.63Sell
MA100
41.59Sell
41.69Sell
MA200
42.05Sell
42.07Sell
Biotest AG’s (0N6Z) 10-Day exponential moving average is 41.49, while Biotest AG’s (0N6Z) share price is €41.2, making it a Sell.
Biotest AG’s (0N6Z) 100-Day exponential moving average is 41.69, while Biotest AG’s (0N6Z) share price is €41.2, making it a Sell.
Biotest AG’s (0N6Z) stock price is €41.2 and Biotest AG’s (0N6Z) 50-day simple moving average is 41.52, creating a Sell signal.
Biotest AG’s (0N6Z) stock price is €41.2 and Biotest AG’s (0N6Z) 100-day simple moving average is 41.59, creating a Sell signal.
Biotest AG’s (0N6Z) stock price is €41.2 and Biotest AG’s (0N6Z) 200-day simple moving average is 42.05, creating a Sell signal.

Biotest (0N6Z) Technical Indicators

Feb 23, 2025, 12:05 AM
Name
Value
Implied Action
RSI (14)
17.63
Buy
STOCH (9,6)
0.00
Neutral
STOCHRSI (14)
0.00
Neutral
MACD (12,26)
-0.11
Buy
ADX (14)
-
Williams %R
-100.00
Buy
CCI (14)
-133.33
Buy
ATR (14)
0.05
-
Ultimate Oscillator
0.00
Sell
ROC
-1.90
Sell
Biotest AG’s (0N6Z) Relative Strength Index (RSI) is 17.63, creating a Buy signal.
Biotest AG’s (0N6Z) Commodity Channel Index (CCI) is -133.33, creating a Buy signal.
Biotest AG’s (0N6Z) Price Rate of Change (ROC) is -1.90, creating a Sell signal.

FAQ

Is 0N6Z a Buy, Hold, or Sell?
Based on 0N6Z’s technical indicators, 0N6Z is a Strong Sell.
    What is 0N6Z’s RSI (14)?
    0N6Z’s RSI (14) is 17.63, which suggests 0N6Z is a Buy.
      What is 0N6Z’s MACD?
      0N6Z’s MACD is -0.11, which suggests 0N6Z is a Buy.
        What is 0N6Z’s 5-day moving average?
        0N6Z’s 5-day moving average is 41.20, which suggests 0N6Z is a Sell.
          What is 0N6Z’s 20-day moving average?
          0N6Z 20-day moving average is 41.80, which suggests 0N6Z is a Sell.
            What is 0N6Z’s 50-day moving average?
            0N6Z’s 50-day moving average is 41.52, which suggests 0N6Z is a Sell.
              What is 0N6Z’s 200-day moving average?
              0N6Z’s 200-day moving average is 42.05, which suggests 0N6Z is a Sell.
                What is 0N6Z’s Williams % R (14)?
                0N6Z’s Williams % R (14) is -100.00, which suggests 0N6Z is a Buy.
                  What is 0N6Z’s CCI (14)?
                  0N6Z’s CCI (14) is -133.33, which suggests 0N6Z is a Buy.
                    What is the share price of Biotest AG?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis